Clinical trials - Press Releases

Date	Title	Company
22-Dec-2020	Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study	Bone Therapeutics
22-Dec-2020	Chi-Med to Present at the 39th Annual JP Morgan Healthcare Conference	Chi-Med
22-Dec-2020	Update on the recently acquired NTCD-M3 biotherapeutic clinical programme for prevention of recurrence of C. difficile infections	Destiny Pharma plc
22-Dec-2020	GLOBAL TEAM OF SCIENTISTS UNITE TO ASSESS ROLE OF T CELLS IN THE BATTLE AGAINST COVID-19 AND EVALUATE STEPS IN MANAGING AND PROTECTING AGAINST FUTURE INFECTIOUS DISEASE	Global T cell Expert Consortium
22-Dec-2020	Bone Therapeutics finalise le recrutement et le traitement des patients dans son étude pivot de Phase III évaluant le JTA-004 dans l’arthrose du genou	Bone Therapeutics
22-Dec-2020	VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)	Vifor Pharma Group
22-Dec-2020	UKCPA Meets Demand For Critical Care Training With New Online	The UK Clinical Pharmacy Association (UKCPA)
22-Dec-2020	Transgene and BioInvent receive CTA approval for Phase 1/2a trial of oncolytic virus BT-001 in solid tumors	Transgene
22-Dec-2020	Janssen Announces European Commission Authorisation of the First Complete Long-Acting Injectable HIV Treatment in Europe	Janssen Pharmaceutical Companies of Johnson & Johnson
22-Dec-2020	GLOBAL HEALTHCARE SECTOR INVESTS OVER £1.3 MILLION TO BOOST INTERNAL COMMUNICATIONS	St George’s University Hospitals NHS Foundation Trust
22-Dec-2020	Exclusive Interview with Mark DePristo, BigHat BioScience speaker at AI in Drug Discovery 2021	SMi Group
21-Dec-2020	GermFlare Searchlight passes Validation Testing against SARS-CoV-2	GermFlare
21-Dec-2020	Tiziana Life Sciences PLC (“Tiziana” or “the Company”) - Notification of proposed admission to the Main Market and cancellation of trading on AIM	Tiziana Life Sciences plc
21-Dec-2020	Sosei Heptares and GSK Enter Global Collaboration and License Agreement Targeting Immune Disorders of the Digestive System	Sosei Group Corporation
21-Dec-2020	54% of UK healthcare professionals say factors other than patients’ best interests influence their medical decision-making	NHS
21-Dec-2020	Nanoform and Herantis partner to look for opportunities to enhance BBB penetration of CDNF and xCDNF molecules	Nanoform Finland Plc
21-Dec-2020	UK wide sites announced as preferred bidders for National Training Centres for the Advanced Therapies Skills Training Network	The National Horizons Centre
21-Dec-2020	AstraZeneca’s Tagrisso approved in US for adjuvant treatment of early-stage lung cancer patients	AstraZeneca
21-Dec-2020	Shionogi's novel antibiotic Fetcroja selected by NICE/ NHSE&I as part of a new pilot subscription reimbursement scheme for antimicrobials	Shionogi & Co., Ltd
21-Dec-2020	GLOBAL TEAM OF SCIENTISTS UNITE TO ASSESS ROLE OF T CELLS IN THE BATTLE AGAINST COVID-19 AND EVALUATE STEPS IN MANAGING AND PROTECTING AGAINST FUTURE INFECTIOUS DISEASE	Global T cell Expert Consortium (GTEC)